Processa Pharmaceuticals, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| CITADEL ADVISORS LLC | 02/14/2024 | 315,410 | $105,536 | 89.75% | 1.17% |
| VANGUARD GROUP INC | 03/11/2024 | 234,653 | $78,515 | -31.87% | 0.87% |
| GEODE CAPITAL MANAGEMENT, LLC | 02/13/2024 | 122,033 | $40,832 | -20.07% | 0.45% |
| UBS GROUP AG | 02/09/2024 | 80,023 | $26,808 | 11,218.67% | 0.30% |
| SPINNAKER TRUST | 02/02/2024 | 76,865 | $25,719 | 100.00% | 0.28% |
| COASTAL BRIDGE ADVISORS, LLC | 02/15/2024 | 64,956 | $21,734 | 23.73% | 0.24% |
| RENAISSANCE TECHNOLOGIES LLC | 02/13/2024 | 58,200 | $19,000 | 7.98% | 0.22% |
| ROYAL BANK OF CANADA | 02/14/2024 | 46,306 | $15,000 | -0.16% | 0.17% |
| STATE STREET CORP | 02/14/2024 | 42,786 | $14,316 | 0.00% | 0.16% |
| NORTHERN TRUST CORP | 02/13/2024 | 28,139 | $9,415 | 82.71% | 0.10% |
| TWO SIGMA INVESTMENTS, LP | 02/14/2024 | 18,677 | $6,249 | 100.00% | 0.07% |
| MCCOLLUM CHRISTOFERSON GROUP LLC | 01/19/2024 | 12,500 | $4,182 | 100.00% | 0.05% |
| COURIER CAPITAL LLC | 01/17/2024 | 12,000 | $4,015 | 100.00% | 0.04% |
| HRT FINANCIAL LP | 02/09/2024 | 11,717 | $3,000 | -39.43% | 0.04% |
| WELLS FARGO & COMPANY/MN | 02/09/2024 | 3,247 | $1,087 | 0.28% | 0.01% |
| ALLWORTH FINANCIAL LP | 01/24/2024 | 1,700 | $569 | 0.00% | 0.01% |
| TOWER RESEARCH CAPITAL LLC (TRC) | 02/13/2024 | 1,195 | $400 | -88.16% | 0.00% |
| BLACKROCK INC. | 02/13/2024 | 293 | $98 | 0.00% | 0.00% |
| JPMORGAN CHASE & CO | 12/26/2024 | 0 | $0 | -100.00% | 0.00% |
| MILLENNIUM MANAGEMENT LLC | 02/14/2024 | 0 | $0 | -100.00% | 0.00% |
| VIRTU FINANCIAL LLC | 02/26/2024 | 0 | $0 | -100.00% | 0.00% |
| MACROVIEW INVESTMENT MANAGEMENT LLC | 01/30/2024 | 0 | $0 | -100.00% | 0.00% |
| MIRADOR CAPITAL PARTNERS LP | 01/19/2024 | 0 | $0 | -100.00% | 0.00% |
| WALLEYE CAPITAL LLC | 02/14/2024 | 0 | $0 | -100.00% | 0.00% |
Processa Pharmaceuticals, Inc.institutional Ownership - FAQ's
What percentage of Processa Pharmaceuticals, Inc. stock is owned by
institutional investors?
4.19% of Processa Pharmaceuticals, Inc. stock is owned by institutional investors.